1. Wasley A, Samandari T, Bell B. Incidence of hepatitis
A in the United States in the era of vaccination. JAMA. 2003;294(2):194-201.
2. Bower WA, Nainan OV, Han X, Margolis HS. Duration of viremia
in hepatitis A infection. J Infect Dis. 2000;182(1):12-17.
3. Victor JC, Monto AS, Surdina TY, et al. Hepatitis A vaccine
versus immune globulin for postexposure prophylaxis. N Engl
J Med. 2007;357(17):1685-1694.
4. American Academy of Pediatrics, Committee on Infectious Diseases.
Hepatitis A vaccine recommendations. Pediatrics. 2007;120(1):189-199.
5. del Canho R, Grosheide PM, Schalm SW, de Vries RR, Heijtink
RA. Failure of neonatal hepatitis B vaccination: the role of HBV-DNA
levels in hepatitis B carrier mothers and HLA antigens in neonates. J
Hepatol. 1994;20(4):483-486.
6. Chen CJ, Yang HI, Su J, et al. for the REVEAL-HBV Study Group.
Risk of hepatocellular carcinoma across a biological gradient of
serum hepatitis B virus DNA level. JAMA. 2006;295(1):65-73.
7. Chang MH. Hepatitis B virus infection. Semin Fetal
Neonatal Med. 2007;12(3):160-167.
8. Jonas MM, Kelley DA, Mizerski J, et al. for the International
Pediatric Lamivudine Investigational Group. Clinical trial of lamivudine
in children with chronic hepatitis B. N Engl J Med. 2002;346(22):1706-1713.
9. Hagmann S, Chung M, Rochford G, et al. Response to lamivudine
treatment in children with chronic hepatitis B virus infection. Clin Infect
Dis. 2003;37(11):1434-140.
10. Chang, MH, Chen, CJ, Lai MS, et al. for the Taiwan Childhood
Hepatoma Study Group. Universal hepatitis B vaccination in Taiwan
and the incidence of hepatocellular carcinoma in children. N
Engl J Med. 1997;336(26):1855-1859.
11. Papaevangelou V, Pollack H, Rochford G, et al. Increased
transmission of vertical hepatitis C virus (HCV) infection to human
immunodeficiency virus (HIV)-infected infants of HIV- and HCV-coinfected
women. J Infect Dis. 1998;178(4):1047-1052.
12. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence
of hepatitis C virus infection in the United States, 1988 through
1994. N Engl J Med. 1999;341(8):556-562.
13. Goodman ZD, Makhlouf HR, Liu L, et al. Pathology of chronic
hepatitis C in children: Liver biopsy findings in the Peds-C Trial. Hepatology. 2007;47(3):836-843.
14. Vogt M, Lang T, Frosner G, et al. Prevalence and clinical
outcome of hepatitis C infection in children who underwent cardiac
surgery before the implementation of blood-donor screening. N
Engl J Med. 1999;341(12):866-870.
15. González-Peralta RP, Kelly DA, Haber B, et al. for
the International Pediatric Hepatitis C Therapy Group. Interferon
alfa-2b in combination with
ribavirin for the treatment of chronic
hepatitis C in children: efficacy, safety, and pharmacokinetics.
Hepatology. 2005;42(5):1010-1018.
16. Jaeckel E, Cornberg M, Wedemyer H, et al. Treatment of acute
hepatitis C with interferon alfa-2b. N Engl J Med. 2001;345(2):1452-1457.
17. Hartman C, Berkowitz D, Rimon N, Shamir R. The effect of
early treatment in children with chronic hepatitis. J Pediatr
Gastroenterol Nutr. 2002;37(3):252-257.
18. Tam AW, Smith MM, Guerra ME, et al. Hepatitis E virus (HEV):
molecular cloning and sequencing of the full-length genome. Virology. 1991;185(1):120-131.
19. Jilani N, Das BC, Husain SA, et al. Hepatitis E virus infection
and fulminant hepatic failure during pregnancy. Hepatology. 2007;22(5):676-682.
20. Kumar RM, Uduman S, Rana S, Kochiyil JK, et al. Sero-prevalence
and mother-to-infant transmission of hepatitis E virus among pregnant women
in the United Arab Emirates. Eur J Obstet Gynecol Reprod
Biol. 2001;100(1):9-15.
21. Roberts E. Neonatal hepatitis syndrome. Semin Neonatol. 2003;8(5):357-374.